-

Shareholder Alert: Robbins LLP Announces Crown Castle International Corp. (CCI) Sued for Misleading Shareholders

SAN DIEGO & HOUSTON--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Crown Castle International Corp. (NYSE: CCI) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 26, 2018 and February 26, 2020. Crown Castle operates and leases more than 40,000 cell towers and more than 75,000 route miles of fiber supporting small cells and fiber solutions.

If you suffered a loss as a result of Crown Castle's misconduct, click here.

Crown Castle International Corp. (CCI) Accused of Misleading Shareholders

According to the complaint, from February 26, 2018 to November 4, 2019, Crown Castle attested to its accuracy of financial reporting, disclosure of its internal control over financial reporting, and disclosure of all fraud in its quarterly and annual reports submitted to the SEC. Beginning in first quarter 2019, Crown Castle touted successive increases in its quarterly net income and increases in adjusted EBITDA, citing "net growth in [its] Towers and Fiber segments." However, on February 26, 2020, Crown Castle revealed that "after consultation with the [SEC's Office of the Chief Accountant], we concluded that our historical practice [for recognizing services revenues] was not acceptable under [Generally Accepted Accounting Principles]." As a result, the Company announced it would restate its financial statements for 2017, 2018, and the first three quarters of 2019, anticipating a decrease of approximately $100 million in net income and adjusted EBITDA for full year 2019 actuals. On this news, the stock price fell $14.38, or almost 9%­­ to close at $148.31 per share.

Crown Castle International Corp. (CCI) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Crown Castle International Corp.

NYSE:CCI

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Crown Castle International Corp.

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom